Wells Fargo
MRNA icon

Wells Fargo’s Moderna MRNA Stock Holding History

Wells Fargo’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-18,000
Closed -$748K – 7174
2024
Q4 		$748K Buy
18,000
+5,500
+44% +$263K ﹤0.01% 3906
2024
Q3 		$835K Buy
12,500
+8,400
+205% +$771K ﹤0.01% 3662
2024
Q2 		$487K Sell
4,100
-15,900
-80% -$2.01M ﹤0.01% 3931
2024
Q1 		$2.13M Sell
20,000
-70,000
-78% -$7.06M ﹤0.01% 2921
2023
Q4 		$8.95M Buy
+90,000
New +$7.57M ﹤0.01% 1789
2023
Q3 		– Sell
-4,000
Closed -$486K – 7644
2023
Q2 		$486K Buy
4,000
+3,400
+567% +$454K ﹤0.01% 3962
2023
Q1 		$92.1K Hold
600
– – ﹤0.01% 4846
2022
Q4 		$108K Buy
+600
New +$98.1K ﹤0.01% 4494

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo's MRNA Position: Q1 2026 in Review

Wells Fargo increased its Moderna (MRNA) stake by 15% in Q1 2026, buying an estimated $884K and bringing the position to 143,765 shares worth $7.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2276.

Wells Fargo first reported a position in MRNA in Q4 2018 and has held it in 30 quarters since. The position peaked at $220M in Q3 2021. 723 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

  • Wells Fargo held 143,765 shares of Moderna worth $7.3M as of Q1 2026.
  • Wells Fargo bought 18,958 Moderna shares in Q1 2026, an estimated $884K.
  • Moderna made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #2276 holding.
  • Wells Fargo first reported a position in Moderna in Q4 2018 and has held it in 30 quarters since.
  • Wells Fargo's Moderna position peaked at $220M in Q3 2021.
  • 723 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.